Home › NDC Lookup › RxCUI directory › RxCUI 104884

Metoclopramide 1 MG/ML Oral Solution — RxCUI 104884

RxNorm drug concept · Semantic clinical drug
RxCUI 104884 Semantic clinical drug · SCD ● Current RxNorm concept 13 FDA products 16 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI104884
Official nameMetoclopramide 1 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmetoclopramide 5 MG per 5 ML Oral Solution; metoclopramide 5 MG in 5 mL Oral Solution; metoclopramide (as the monohydrochloride monohydrate) 5 MG per 5 ML Oral Solution
FDA products mapped13
Package NDCs mapped16
Reported Medicaid activity (SDUD)27,880 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Metoclopramide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • The injection form works much faster than a pill — within 1 to 3 minutes through the vein or about 10 to 15 minutes through the muscle. That makes it the right choice when you need...
  • Why am I getting metoclopramide as an injection instead of a pill?
  • Tardive dyskinesia (TD) means uncontrolled, repetitive movements — often lip smacking, tongue movements, or facial grimacing — that can sometimes become permanent. It's the most im...
  • What is tardive dyskinesia, and how worried should I be about it?
📖 Read our full Metoclopramide Injection guide →

🕸️ Concept Web — How Metoclopramide 1 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Metoclopramide 1 MG/ML Oral Solution RxCUI 104884

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Metoclopramide 6915
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Metoclopramide Oral Solution 372883
    • Metoclopramide Oral Liquid Product 1163512
    • Metoclopramide Oral Product 1163513
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Metoclopramide 1 MG/ML 328462

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Metoclopramide 1 MG/ML SCDC · 328462
  • Metoclopramide Oral Solution SCDF · 372883
  • Metoclopramide Oral Liquid Product SCDG · 1163512
  • Metoclopramide Oral Product SCDG · 1163513

📦 FDA Products & Package NDCs

13 products · 16 package NDCs
16 package NDCs map to RxCUI 104884 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00121-0576-16 473 mL in 1 BOTTLE (0121-0576-16) Metoclopramide PAI Holdings, LLC dba PAI Pharma 1991-06-01
00121-1576-10 10 TRAY in 1 CASE (0121-1576-10) / 10 CUP, UNIT-DOSE in 1 T... Metoclopramide PAI Holdings, LLC dba PAI Pharma 1991-06-01
17856-1190-01 72 CUP, UNIT-DOSE in 1 CASE (17856-1190-1) / 5 mL in 1 CUP,... Metoclopramide ATLANTIC BIOLOGICALS CORP. 2025-08-21
17856-1190-02 120 SYRINGE in 1 CASE (17856-1190-2) / 1 mL in 1 SYRINGE Metoclopramide ATLANTIC BIOLOGICALS CORP. 2025-08-21
60687-0837-56 10 TRAY in 1 CASE (60687-837-56) / 10 CUP, UNIT-DOSE in 1 T... Metoclopramide American Health Packaging 2024-11-12
62135-0526-24 2 TRAY in 1 BOX (62135-526-24) / 10 CUP in 1 TRAY / 10 mL i... metoclopramide hydrochloride Chartwell RX, LLC 2024-10-14
62135-0526-47 473 mL in 1 BOTTLE (62135-526-47) metoclopramide hydrochloride Chartwell RX, LLC 2023-03-21
62559-0190-16 473 mL in 1 BOTTLE, PLASTIC (62559-190-16) Metoclopramide ANI Pharmaceuticals, Inc. 2015-05-18
63629-1961-01 473 mL in 1 BOTTLE (63629-1961-1) Metoclopramide Bryant Ranch Prepack 2021-02-04
63629-2144-01 473 mL in 1 BOTTLE (63629-2144-1) Metoclopramide Bryant Ranch Prepack 2021-02-08
64950-0344-16 473 mL in 1 BOTTLE, PLASTIC (64950-344-16) Metoclopramide Genus Lifesciences Inc. 2024-06-01
68999-0526-24 2 TRAY in 1 BOX (68999-526-24) / 10 CUP in 1 TRAY / 10 mL i... metoclopramide hydrochloride Chartwell Governmental & Specialty RX, LLC. 2025-10-29
71335-2732-01 473 mL in 1 BOTTLE, PLASTIC (71335-2732-1) Metoclopramide Bryant Ranch Prepack 2025-07-29
71335-2997-01 473 mL in 1 BOTTLE (71335-2997-1) Metoclopramide Bryant Ranch Prepack 2025-11-05
72162-1750-02 473 mL in 1 BOTTLE, PLASTIC (72162-1750-2) Metoclopramide Bryant Ranch Prepack 2023-10-06
72162-1750-04 473 mL in 1 BOTTLE, PLASTIC (72162-1750-4) Metoclopramide Bryant Ranch Prepack 2023-10-06
Observed labelers: Bryant Ranch Prepack (6) · ATLANTIC BIOLOGICALS CORP. (2) · Chartwell RX, LLC (2) · PAI Holdings, LLC dba PAI Pharma (2) · American Health Packaging (1) · ANI Pharmaceuticals, Inc. (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.1280
Range $0.1273–$0.1280 · middle 50% $0.1278–$0.1280 · 4 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.